Author:
Farber N B,Kim S H,Dikranian K,Jiang X P,Heinkel C
Publisher
Springer Science and Business Media LLC
Subject
Cellular and Molecular Neuroscience,Psychiatry and Mental health,Molecular Biology
Reference74 articles.
1. Domino EF, Luby ED . Abnormal mental states induced by phencyclidine as a model of schizophrenia. In: Domino EF (ed) PCP (Phenyclidine): Historical and Current Perspectives NPP Books: Ann Arbor 1981 401–418
2. Javitt DC, Zukin SR . Recent advances in the phenyclidine model of schizophrenia Am J Psychiatry 1991 148: 1301–1308
3. Kristensen JD, Svensson B, Gordh T . The NMDA receptor-antagonist CPP abolishes neurogenic ‘wind-up pain’ after intrathecal administration in humans Pain 1992 51: 249–253
4. Herrling P . D-CPPene (SDZ EAA 494), a competitive NMDA antagonist. Results from animal models and first results in humans Neuropsychopharmacology 1994 10: (3S/Part 1): 591S
5. Krystal JH, Karper LP, Seibyl JP, Freeman GK, Delaney R, Bremner JD et al. Subanesthetic effects of the noncompetitive NMDA antagonist, Ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses Arch Gen Psychiatry 1994 51: 199–214
Cited by
87 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献